What's in Beijing Biostar Pharmaceuticals Co., Ltd.'s pipeline?

Beijing Biostar Pharmaceuticals Co., Ltd. has 4 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 2 in Phase 2, 1 in Phase 1.

Which companies overlap with Beijing Biostar Pharmaceuticals Co., Ltd.'s portfolio?

Top competitors by shared drug class: Asan Medical Center, Assistance Publique - Hôpitaux de Paris, Associazione Italiana per lo Studio del Pancreas, AstraZeneca, BeiGene.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/beijing-biostar-pharmaceuticals-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Beijing Biostar Pharmaceuticals Co., Ltd. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Beijing Biostar Pharmaceuticals Co., Ltd. pipeline: 0 marketed, 0 filed, 1 Phase 3, 2 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 2 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
UTD1 Injection plus capecitabine	UTD1 Injection plus capecitabine	phase 3	Chemotherapy	Thymidylate synthase	Oncology

Therapeutic area mix

Oncology · 2

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Asan Medical Center · 1 shared drug class
Assistance Publique - Hôpitaux de Paris · 1 shared drug class
Associazione Italiana per lo Studio del Pancreas · 1 shared drug class
AstraZeneca · 1 shared drug class
BeiGene · 1 shared drug class
Cephalon, Inc. · 1 shared drug class
Delcath Systems Inc. · 1 shared drug class
Acrotech Biopharma Inc. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Beijing Biostar Pharmaceuticals Co., Ltd.:

Cite this brief

Drug Landscape (2026). Beijing Biostar Pharmaceuticals Co., Ltd. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/beijing-biostar-pharmaceuticals-co-ltd. Accessed 2026-05-16.